| Â | Unmatched cohort | Matched cohort |
|---|
OR (95% CI) | P | OR (95% CI) | P |
|---|
Model 1 | 1.08 (1.02–1.13) |  < 0.001 | 1.07 (1.01–1.14) | 0.026 |
Model 2 | 1.11 (1.06–1.17) |  < 0.001 | 1.07 (1.01–1.14) | 0.024 |
Model 3 | 1.11 (1.06–1.17) |  < 0.001 | 1.08 (1.01–1.14) | 0.017 |
Model 4 | 1.10 (1.05–1.17) |  < 0.001 | 1.08 (1.01–1.14) | 0.016 |
Model 5 | 1.08 (1.02–1.14) |  < 0.001 | 1.08 (1.01–1.14) | 0.017 |
Model 6 | 1.07 (1.01–1.13) | 0.028 | 1.07 (1.01–1.14) | 0.033 |
- SA-AKI Sepsis associated acute kidney injury, BMI Body mass index, CI confidence intervals, OR odds ratio
- Model 1, unadjusted; Model 2, adjusted for age; Model 3, adjusted for adjusted for age, BMI, race, admission type, infection resources, microorganisms; Model 4, adjusted for age, race, BMI, admission type, infection resources, microorganisms, hypertension, coronary atherosclerosis, chronic heart failure, chronic liver disease, diabetes,chronic kidney disease, peripheral vascular disease, chronic pulmonary disease, cancer; Model 5, adjusted for age, race, BMI, admission type, infection resources, microorganisms, hypertension, coronary atherosclerosis, chronic heart failure, chronic liver disease, diabetes, chronic kidney disease, peripheral vascular disease, chronic pulmonary disease, cancer, KRT, Mechnical ventilation, Vasopressor use, Diuretic, Statin, ACEI/ARBs, Contrast, Vancomycin, Aminoglycosides; Model 6, adjusted for age, race, BMI, admission type, infection resources, microorganisms, hypertension, coronary atherosclerosis, chronic heart failure, chronic liver disease, diabetes, chronic kidney disease, peripheral vascular disease, chronic pulmonary disease, cancer, KRT, Mechnical ventilation, Vasopressor use, Diuretic, Statin, ACEI/ARBs, Contrast, Vancomycin, Aminoglycosides, apsiii, sofa, oasis, sapsII, BUN, Creatinine, Potassium, Chloride, PT, Hemoglobin, Lactate, NLR, Proteinuria, Pao2/Fio2, PO2, Bicarbonate, MAP, Temperature
